Role of endothelium and nitric oxide in experimental hypertension

Physiological Research

Volumn 49, Issue 1, 2000, Pages 1-10

  Vapaatalo, H ^a   Mervaala, E ^a   Nurminen, M L ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Antihypertensive drugs; Dysfunction; Endothelium; Hypertension; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CYCLIC GMP; CYCLOSPORIN A; DEOXYCORTICOSTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FELODIPINE; ISOPRENALINE; ISOSORBIDE 5 NITRATE; METOPROLOL; MOXONIDINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; QUINAPRIL; RAMIPRIL; VALSARTAN;

ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; BLOOD VESSEL TONE; EXPERIMENTAL MODEL; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; NONHUMAN; RENOVASCULAR HYPERTENSION; SHORT SURVEY; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIHYPERTENSIVE AGENTS; DIET; ENDOTHELIUM, VASCULAR; HEMODYNAMIC PROCESSES; HYPERTENSION; NITRIC OXIDE; RATS; RATS, INBRED SHR;

EID: 0033952420     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (82)

1. ANDOH TF, GARDNER MP, BENNET WM: Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity. Transplantation 64: 1236-1250, 1997.
2. ARVOLA P, RUSKOAHO H, WUORELA H, PEKKI A, VAPAATALO H, PÖRSTI I: Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats. Br J Pharmacol 108: 980-990, 1993.
3. ASSIS SM, MONTEIRO JL, SEGURO AC: L-arginine and allopurinol protect against cyclosporine nephrotoxicity. Transplantation 63: 1070-1073, 1997.
4. BACHMANN S, MUNDEL P: Nitric oxide in the kidney: synthesis, localization, and function. Am J Kidney Dis 24: 112-129, 1994.
5. BAYRAKTUTAN U, YANG Z-K, SHAH AK: Selective dysregulation of nitric oxide synthase type 3 in cardiac myocytes but not coronary microvascular endothelial cells of spontaneously hypertensive rat. Cardiovasc Res 38: 719-726, 1998.
6. BOBADILLA NA, TAPIA E, FRANCO M, LÓPEZ P, MENDOZA S, GARCÍA-TORRES R, ALVARADO JA, HERRERA-ACOSTA J: Role of nitric oxide in renal hemodynamic abnormalities of cyclosporin nephrotoxicity. Kidney Int 46: 773-779, 1994.
7. BOBADILLA NA, GAMBA G, TAPIA E, GARCÍA-TORRES R, BOLIO A, LÓPEZ-ZETINA P, HERRERA-ACOSTA J: Role of NO in cyclosporin nephrotoxicity: effects of chronic NO inhibition and NO synthases gene expression. Am J Physiol 275: F791-F798, 1998.
8. BORN G, RABELINK T, SMITH T (eds): Endothelium and Cardiovascular Disease. Science Press Ltd, London, 1998. pp 1-50.
9. BUGA GM, GOLD ME, FUKUTO JM, IGNARRO L: Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 17: 187-193, 1991.
10. CHEN PY, SANDERS PW: L-arginine abrogates salt sensitive hypertension in Dahl/Rapp rats. J Clin Invest 88: 1559-1567, 1991.
11. COWLEY AW, MATTSON DL, LU S, ROMAN RJ: The renal medulla and hypertension. Hypertension 25: 663-673, 1995.
12. CUNHA RS, CABRAL AM, VASQUEZ EC: Evidence that the autonomic nervous system plays a major role in the L-NAME-induced by hypertension in conscious rats. Am J Hypertens 6: 806-809, 1993.
13. DAS S, KUMAR KN: Nitric oxide: its identity and role in blood pressure control. Life Sci 57: 1547-1556, 1995.
14. DENG AY: Is the nitric oxide system involved in genetic hypertension in Dahl rats? Kidney Int 53: 1501-1511, 1998.
15. DOHI Y, CRISCIONE L, LÜSCHER TF: Renovascular hypertension impairs formation of endothelium-derived relaxing factors and sensitivity to endothelin-I in resistance arteries. Br J Pharmacol 104: 349-354, 1991.
16. DUBEY RK, BOEGEHOLD MA, GILLESPIE DG, ROSSELLI M: Increased nitric oxide activity in early renovascular hypertension Am J Physiol 270: R118-R124, 1996.
17. FENOY FJ, FERRER P, CARBONEL L, SALOM MG: Role of nitric oxide on papillary blood flow and pressure natriuresis. Hypertension 25: 408-414, 1995.
18. FURCHGOTT RF, ZAWADZKI JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
19. GARDINER SM, KEMP PA, BENNETT T, PALMER RM, MONCADA S: Nitric oxide synthase inhibitors cause sustained, but reversible, hypertension and hindquarters vasoconstriction in Brattleboro rats. Eur J Pharmacol 213: 449-451, 1992.
20. GARTHWAITE J: Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 14: 60-67, 1991.
21. GRYGLEWSKI RJ: Interactions between endothelial mediators. Pharmacol Toxicol 77: 1-9, 1995.
22. GRYGLEWSKI RJ, BUNTING S, MONCADA S, FLOWER RJ, VANE JR: Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins 12: 685-713, 1976.
23. HAYAKAWA H, HIRATA Y, SUZUKI E, KIMURA K, KIKUCHI K, NAGANO T, HIROBE M, OMATA M: Long term administration of L-arginine improves nitric oxide release from kidney in deoxycorticosterone acetate salt hypertensive rats. Hypertension 23: 752-756, 1994.
24. HUANG PL, DAWSON TM, BREDT DS, SNYDER SH, FISHMAN MC: Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75: 1273-1286, 1993.
25. HUANG PL, HUANG Z, MASHIMO H, BLOCH KD, MOSKOWITZ MA, BEVAN JA, FISHMAN MC: Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242, 1995.
26. IGNARRO LJ, BUGA GM, WOOD KS, BYNS RE, CHAUDHURI G: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269, 1987.
27. IMAOKA Y, OSANAI T, KAMADA T, MIO Y, SATOH K, OKUMURA K: Nitric oxide-dependent vasodilator mechanism is not impaired by hypertension but is diminished with aging in the rat aorta. J Cardiovasc Pharmacol 33: 756-766, 1999.
28. ITO S: Nitric oxide in the kidney. Curr Opin Nephrol Hypertens 4: 23-30, 1995.
29. KHAN MT, FURCHGOTT RF: Additional evidence that endothelium-derived relaxing factor is nitric oxide. In: Pharmacology, RAND MJ, RAPER C (eds). Elsevier, Amsterdam, 1987, pp 341-344.
30. KONE BC, BAYLIS C: Biosynthesis and homeostatic roles of nitric oxide in the kidney. Am J Physiol 272: F561-F578, 1997.
31. KURIHARA N, ALFIE ME, SIGMON DH, RHALEB N-E, SHESELY EG, CARRETERO OA: Role of nNOS in blood pressure regulation in eNOS null mutant mice. Hypertension 32: 856-861, 1998.
32. LASSILA M, FINCKENBERG P, PERE A-K, VAPAATALO H, NURMINEN M-L: Enalapril and valsartan improved cyclosporine A-induced vascular dysfunction in spontaneously hypertensive rats. 1999. Eur J Pharmacol (submitted).
33. LAUBACH VE, SHESELY EG, SMITHIES O, SHERMAN PA: Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 92: 10688-10692, 1995.
34. LAURANT P, DEMOLOMBE B, BERTHELOT A: Dietary L-arginine attenuates blood pressure in mineralocorticoid salt hypertensive rats. Clin Exp Hypertens 17: 1009-1024, 1995.
35. LOCKETTE W, OTSUKA Y, CARRETERO OA: The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 23: 61-66, 1986.
36. LÜSCHER TF, VANHOUTTE PM: Mechanisms of altered endothelium-dependent responses in hypertensive blood vessels. In: Relaxing and Contracting Factors. PM VANHOUTTE (ed), Humana Press, Clifton, N.J., 1988, pp 495-509.
37. LÜSCHER TF, RAIJ L, VANHOUTTE PM: Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension 9: 157-163, 1987.
38. MACMICKING JD, NATHAN C, HOM G, CHARTRAIN N, FLETCHER DS, TRUMBAUER M, STEVENS K, XIE Q, SOKOL K, HUTCHINSON H, CHEN H, MUDGET JS: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 61: 641-650, 1995.
39. MÄKYNEN H, ARVOLA P, VAPAATALO H, PÖRSTI I: High calcium diet effectively opposes the development of deoxycorticosterone-salt hypertension in rats. Am J Hypertens 7: 520-528, 1994.
40. MÄKYNEN H, KÄHÖNEN M, ARVOLA P, WUORELA H, VAPAATALO H, PÖRSTI I: Dietary calcium and magnesium supplements in spontaneously hypertensive rats and isolated arterial reactivity. Br J Pharmacol 115: 1455-1462, 1995.
41. MERVAALA E, MALMBERG L, TERÄVÄINEN T-L, LÄHTEENMÄKI T, KARJALA K, PAAKKARI I, PÖRSTI I, MEST H-J, VAPAATALO H, KARPPANEN H: Influence of different dietary salts on the cardiovascular and renal effects of moxonidine in spontaneously hypertensive rats. Naunyn-Schmiedeberg's Arch Pharmacol 356: 107-114, 1997a.
42. MERVAALA EMA, TERÄVÄINEN T-L, MALMBERG L, LAAKSO J, PÖRSTI I, VAPAATALO H, KARPPANEN H: Cardiovascular and renal effects of the combination of felodipine and metoprolol during a high-salt and a moderate-salt diet in spontaneouslv hypertensive rats. Jpn Circ J 61: 421-431, 1997b.
43. MERVAALA EMA, TERÄVÄINEN T-L, MALMBERG L, LAAKSO J, VAPAATALO H, KARPPANEN H. Cardiovascular effects of a low-dose combination of ramipril and felodipine in spontaneously hypertensive rats. Br J Pharmacol 121: 503-510, 1997c.
44. MERVAALA EMA, MALMBERG L, TERÄVÄINEN T-L, LAAKSO J, VAPAATALO H, KARPPANEN H: Influence of dietary salts on the cardiovascular effects of low-dose combination of ramipril and felodipine in spontaneously hypertensive rats. Br J Pharmacol 123: 195-204, 1998.
45. MONCADA S: Nitric oxide: discovery and impact on clinical medicine. J Roy Soc Med 92: 164-169, 1999.
46. MORTON JJ, BEATTIE EC, SPEIRS A, GULLIVER F: Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy. J Hypenens 11: 1083-1088, 1993.
47. NAKAMURA T, PREWITT RL: Alteration of endothelial function in arterioles of renal hypertensive rats at two levels of vascular tone. J Hypertens 10: 621-627, 1992.
48. NAVA E, LÜSCHER TF: Hypertension. In: Pathophysiology and Clinical Applications of Nitric Oxide, GM RUBANYI (ed), Harwood Academic Publishers, Amsterdam, 1999, pp 251-266.
49. NAVA E, LEONE AM, WIKLUND NP, MONCADA S: Detection of release of nitric oxide by vasoactive substances in the anaesthesized rat. In: The Biology of Nitric Oxide, M FEELISH, R BUSSE, S MONCADA (eds), Portland Press, London, 1994, pp 179-181.
50. NAVA E, NOLL G, LÜSCHER TF: Increased activity of constitutive nitric oxide synthase in hearts from spontaneous hypertensive rats. Circulation 92: 2310-2313, 1995.
51. NAVA E, SALAZAR J, MARTINEZ DE VELASCO J, MARTINEZ-MURILLO R, FERNANDEZ AP, SERRANO J, RODRIGO J: Distribution of neuronal nitric oxide synthase immunoreactivity in normal and hypertensive rat kidneys. J Am Soc Nephrol 7: 1540, 1996.
52. NELSON RJ, DEMAS GE, HUANG PL, FISHMAN MC, DAWSON VL, DAWSON TM, SNYDER SH: Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 378: 383-386, 1995.
53. NURMINEN M-L, VAPAATALO H: Effect of intracerebroventricular and intravenous administration of nitric oxide donors on blood pressure and heart rate in anaesthetized rats. Br J Pharmacol 199: 1422-1426, 1996.
54. NURMINEN M-L, YLIKORKALA A, VAPAATALO H: Central inhibition of nitric oxide synthesis increases blood pressure and heart rate in anesthetized rats. Meth Find Exp Clin Pharmacol 19: 35-41, 1997.
55. OHASHI Y, KAWASHIMA S, HIRATA K-I, YAMASHITA T, ISHIDA T, INOUE N, SAKODA T, KURIHARA H, YAZAKI Y, YOKOYAMA M: Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J Clin Invest 102: 2061-2071, 1998.
56. ORIJI GK, KEISER HR: Role of nitric oxide in cyclosporine A-induced hypertension. Hypertension 32: 849-855, 1998.
57. PALMER RM, FERRIGE AG, MONCADA S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.
58. QIU HY, HENRION D, BENESSIANO J, HEYMES C, TOURNIER B, LEVY BL: Decreased flow-induced dilation and increased production of cGMP in spontaneously hypertensive rats. Hypertension 32: 1098-1103, 1998
59. RADAELLI A, MIRCOLI L, MORI I, MANCIA G, FERRARI AU. Nitric oxide-dependent vasodilation in young spontaneously hypertensive rats. Hypertension 32: 735-739, 1998.
60. RELS D, BEN ISHAY D, MONCADA S: Nitric oxide and the regulation of blood pressure in the hypertension-prone and hypertension-resistant Sabra rat. Hypertension 28: 367-371, 1996.
61. RIBEIRO MO, ANTUNES E, DE-NUCCI G, LOVISOLO SM, ZATZ R: Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 20: 298-303, 1992.
62. RUSSEL FD, DAVENPORT AP: Secretory pathways in endothelin synthesis. Br J Pharmucol 126: 391-398, 1999.
63. SALAZAR FJ, ALBEROLA A, PINILLA JM, ROMERO JC, QUEASADA T: Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension 22: 49-55, 1993.
64. SALLINEN K, ARVOLA P, WUORELA H, RUSKOAHO H, VAPAATALO H, PÖRSTI I: High calcium diet reduces blood pressure in exercised and nonexercised hypertensive rats. Am J Hypertens 9: 144-156, 1996.
65. SCHINI-KERTH VB, VANHOUTTE PM: Nitric oxide synthases in vascular cells. Exp Physiol 80: 885-905, 1995.
66. SNYDER S.H., BREDT D.S.: Biological roles of nitric oxide. Sci Am 266: 68-71, 74-77, 1992.
67. STEUDEL W, ICHINOSE F, HUANG PL, HURFORD WE, JONES RC, BEVAN JA, FISHMAN MC, ZAPOL WM: Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. Circ Res 81: 34-41, 1997.
68. TAKASE H, MOREAU P, KÜNG CF, NAVA E, LÜSCHER TF: Antihypertensive therapy improves endothelium-dependent relaxation of resistance arteries in nitric oxide deficient hypertension: effect of verapramil and trandolapril. Hypertension 27: 25-31, 1996.
69. TERÄVÄINEN T-L, MERVAALA EMA, PÖRSTI I, LAAKSO J, VAPAATALO H, KARPPANEN H: Influence of age and dietary sodium on the cardiovascular and renal effects of ramipril in spontaneously hypertensive rats. Meth Find Exp Clin Pharmacol 19: 311-321, 1997
70. TSENG CJ, LIU HY, LIN HC, GER LP, TUNG CS, YEN MH: Cardiovascular effects of nitric oxide in the brain stem nuclei of rats. Hypertension 27: 36-42, 1996.
71. VALLANCE P, COLLIER J, MONCADA S: Effects of endothelium derived nitric oxide on peripheral arteriolar tone in man. Lancet 2: 997-1000, 1989.
72. VAPAATALO H, NEVALA R, LÄHTEENMÄKI T, MERVAALA E, VASKONEN T, NURMINEN M-L: Role of endothelium and NO in experimental hypertension. Physiol Res 48: 37P, 1999.
73. VASKONEN T, MERVAALA E, KROGERUS L, TERÄVÄINEN T-L, LAAKSO J, KARPPANEN H, VAPAATALO H: Cardiovascular effects of chronic inhibition of nitric oxide synthesis and dietary salt in spontaneously hypertensive rats. Hypertens Res 20: 183-192, 1997.
74. VASKONEN T, MERVAALA E, TERÄVÄINEN T-L, LAAKSO J, KARPPANEN H, VAPAATALO H: Cardiovascular effects of dietary salts and isosorbide-5-mononitrate in spontaneously hypertensive rats. Blood Press 7: 184-192, 1998.
75. VOORDE JV, LEUSEN I: Endothelium dependent and independent relaxation of aortic rings from hypertensive rats. Am J Physiol 250: H711-H717, 1986.
76. WUORELA H, ARVOLA P, KÄHÖNEN M, VAPAATALO H, PÖRSTI I: Arterial smooth muscle responses in adult and moderately aged spontaneously hypertensive rats. Pharmacol Toxicol 74: 167-173, 1994.
77. YANAGISAWA M, KURIHARA H, KIMURA S, TOMOBE Y, KOBAYASHI M, MITSUI Y, YAZAKI Y, GOTO K, MASAKI T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
78. YANG CW, KIM YS, KIM J, KIM YO, MIN SY, CHOI EJ, BANG BK: Oral supplementation of L-arginine prevents chronic cyclosporine nephrotoxicity in rats. Exp Nephrol 6: 50-56, 1998.
79. ZATZ R, BAYLIS C: Chronic nitric oxide inhibition model six years on. Hypertension 32: 958-964, 1998.
80. ZHANG K, MAYHAN WG, PATEL KP: Nitric oxide within the paraventricular nucleus mediates changes in renal sympathetic nerve activity. Am J Physiol 273: R864-R872, 1997.
81. ZICHA J, KUNEŠ J: Ontogenetic aspects of hypertension development: analysis in the rat. Physiol Res 79: 1227-1282, 1999.
82. ZOU AP, COWLEY AW Jr.: Nitric oxide in renal cortex and medulla. An in vivo microdialysis study. Hypertension 29: 194-198, 1997.